Enhanced Supportive Care for Advanced Cancer Patients: Evaluation of Standardized Care Pathway
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of this study is to evaluate the efficacy of the standardized care pathway which provides enhanced supportive care for patients with advanced cancer.
A pilot study (single arm pre-post test) will be conducted to evaluate feasibility of applying standardized care pathway to provide enhanced supportive care. A Randomized Controlled Trial will be conducted by randomly allocating participants in a 1:1 ratio to intervention arm (receiving enhanced supportive care according to the standardized care pathway) or control arm (receiving usual care: symptom monitoring only). Participants in the intervention arm will receive enhanced supportive care consisted of symptom management and coping enhancement counseling for 5 times. Data from advanced cancer patients will be collected at baseline (before start of chemotherapy), during chemotherapy (intervention arm), at the visit for cycle 5 of chemotherapy, at 6 month, and at 12 month Data from caregivers will be collected at baseline, 3 month, and 6 month. Primary outcomes will be measured as advanced cancer patients' symptom, coping and quality of life.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- adult (age >=19 years old),
- cancer patients and their family
- ECOG =<2
Exclusion criteria
- patients with cognitive or psychiatric issue
Trial design
Primary purpose
Allocation
Interventional model
Masking
780 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Jiyeon Lee, Ph.D
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal